This is keeping with previous large-scale metabolic profiling studies [23, 24, 26] and consistent with the pathophysiology of type 2 diabetes, where insulin sensitivity gradually declines years before clinical disease onset [40]. This evidence concerns the gene INS and type 2 diabetes mellitus.